Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
1.76
-0.11 (-6.13%)
At close: May 14, 2025, 3:59 PM
1.75
-0.85%
After-hours: May 14, 2025, 07:01 PM EDT
-6.13% (1D)
| Bid | 1.75 |
| Market Cap | 113.01M |
| Revenue (ttm) | 241K |
| Net Income (ttm) | -95.23M |
| EPS (ttm) | -1.51 |
| PE Ratio (ttm) | -1.17 |
| Forward PE | -0.92 |
| Analyst | Buy |
| Ask | 2.1 |
| Volume | 938,007 |
| Avg. Volume (20D) | 1,035,108 |
| Open | 1.87 |
| Previous Close | 1.88 |
| Day's Range | 1.74 - 1.89 |
| 52-Week Range | 1.61 - 11.20 |
| Beta | 0.87 |
About LRMR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LRMR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LRMR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-21.72%
Larimar Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
6 months ago
+8.74%
Larimar Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results.
4 months ago · seekingalpha.com
Larimar Therapeutics: Positive Friedreich's Ataxia Data Can Only Get BetterLarimar Therapeutics, Inc. reported initial positive data from phase 2 long-term OLE study using nomlabofusp for treatment of patients with Friedreich's Ataxia; Increase of tissue FXN protein levels f...